A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women With Moderate to Severe Primary Dysmenorrhea (With Optional Extension)
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Estradiol/etonogestrel (Primary)
- Indications Dysmenorrhoea
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 16 Sep 2016 Status changed from active, no longer recruiting to discontinued.
- 09 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
- 09 Aug 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.